COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 84 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2017. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $541 | -0.7% | 16,815 | +19.9% | 0.00% | 0.0% |
| Q1 2024 | $545 | -3.0% | 14,030 | -23.1% | 0.00% | -40.0% |
| Q4 2023 | $562 | +154.3% | 18,244 | +84.2% | 0.01% | +66.7% |
| Q3 2023 | $221 | -62.4% | 9,905 | -59.5% | 0.00% | -57.1% |
| Q1 2023 | $587 | -99.6% | 24,472 | +230.5% | 0.01% | +600.0% |
| Q2 2022 | $131,000 | -62.8% | 7,404 | -57.2% | 0.00% | -66.7% |
| Q1 2022 | $352,000 | -42.9% | 17,287 | -47.6% | 0.00% | 0.0% |
| Q4 2021 | $616,000 | -19.5% | 32,985 | -14.9% | 0.00% | -25.0% |
| Q3 2021 | $765,000 | +225.5% | 38,741 | +290.6% | 0.00% | +300.0% |
| Q1 2021 | $235,000 | -34.5% | 9,918 | -51.6% | 0.00% | -66.7% |
| Q2 2020 | $359,000 | +82.2% | 20,494 | +70.1% | 0.00% | +50.0% |
| Q1 2020 | $197,000 | +57.6% | 12,046 | +98.9% | 0.00% | +100.0% |
| Q4 2019 | $125,000 | -18.8% | 6,056 | -38.8% | 0.00% | 0.0% |
| Q4 2016 | $154,000 | – | 9,891 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,887,332 | $32,405,000 | 8.36% |
| SECTORAL ASSET MANAGEMENT INC | 1,156,934 | $19,865,000 | 2.70% |
| 1492 Capital Management LLC | 150,189 | $2,579,000 | 2.31% |
| Eventide Asset Management | 2,207,610 | $37,905,000 | 1.68% |
| J. Goldman & Co LP | 1,066,847 | $18,318,000 | 1.41% |
| HAMILTON LANE ADVISORS LLC | 89,975 | $1,545,000 | 1.35% |
| Rock Springs Capital Management LP | 1,605,105 | $27,560,000 | 1.30% |
| RICE HALL JAMES & ASSOCIATES, LLC | 932,126 | $16,005,000 | 0.58% |
| Opaleye Management Inc. | 80,000 | $1,373,000 | 0.51% |
| Cortina Asset Management, LLC | 456,036 | $7,830,000 | 0.48% |